The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Risk factors for neurodegeneration in idiopathic rapid eye movement sleep behavior disorder: A multicenter study
Open accessAbstract
Objective: To assess whether risk factors for Parkinson disease and dementia with Lewy bodies increase rate of defined neurodegenerative disease in idiopathic rapid eye movement (REM) sleep behavior disorder (RBD). Methods: Twelve centers administered a detailed questionnaire assessing risk factors for neurodegenerative synucleinopathy to patients with idiopathic RBD. Variables included demographics, lifestyle factors, pesticide exposures, occupation, comorbid conditions, medication use, family history, and autonomic/motor symptoms. After 4 years of follow‐up, patients were assessed for dementia or parkinsonism. Disease risk was assessed with Kaplan–Meier analysis, and epidemiologic variables were compared between convertors and those still idiopathic using logistic regression. Results: Of 305 patients, follow‐up information was available for 279, of whom 93 (33.3%) developed defined neurodegenerative disease. Disease risk was 25% at 3 years and 41% after 5 years. Patients who converted were older (difference = 4.5 years, p < 0.001), with similar sex distribution. Neither caffeine, smoking, nor alcohol exposure predicted conversion. Although occupation was similar between groups, those who converted had a lower likelihood of pesticide exposure (occupational insecticide = 2.3% vs 9.0%). Convertors were more likely to report family history of dementia (odds ratio [OR] = 2.09), without significant differences in Parkinson disease or sleep disorders. Medication exposures and medical history were similar between groups. Autonomic and motor symptoms were more common among those who converted. Risk factors for primary dementia and parkinsonism were generally similar, except for a notably higher clonazepam use in dementia convertors (OR = 2.6). Interpretation: Patients with idiopathic RBD are at very high risk of neurodegenerative synucleinopathy. Risk factor profiles between convertors and nonconvertors have both important commonalities and differences. Ann Neurol 2015;77:830–839
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium
McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,069
Adjusting for multiple testing—when and how?
Bender, R., & Lange, S. (2001) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(00)00314-0 · Cited by 3,004
Schenck, C. H., Bundlie, S. R., & Mahowald, M. W. (1996) · Neurology · doi:10.1212/wnl.46.2.388 · Cited by 1,083
Dubois, B., Burn, D., Goetz, C., Aarsland, D., Brown, R. G., Broe, G. A., Dickson, D., Duyckaerts, C., Cummings, J., Gauthier, S., et al. (2007) · Movement Disorders · doi:10.1002/mds.21844 · Cited by 1,082
Assessment of autonomic dysfunction in Parkinson's disease: The SCOPA‐AUT
Visser, M., Marinus, J., Stiggelbout, A. M., & Van Hilten, J. J. (2004) · Movement Disorders · doi:10.1002/mds.20153 · Cited by 831
Schenck, C. H., Boeve, B. F., & Mahowald, M. W. (2013) · Sleep Medicine · doi:10.1016/j.sleep.2012.10.009 · Cited by 814
Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder
Postuma, R. B., Gagnon, J. F., Vendette, M., Fantini, M. L., Massicotte-Marquez, J., & Montplaisir, J. (2009) · Neurology · doi:10.1212/01.wnl.0000340980.19702.6e · Cited by 767
Self-citationBenzodiazepine use and risk of Alzheimer's disease: case-control study
Billioti de Gage, S., Moride, Y., Ducruet, T., Kurth, T., Verdoux, H., Tournier, M., Pariente, A., & Begaud, B. (2014) · BMJ · doi:10.1136/bmj.g5205 · Cited by 558
Neurodegenerative Disorder Risk in Idiopathic REM Sleep Behavior Disorder: Study in 174 Patients
Iranzo, A., Fernández-Arcos, A., Tolosa, E., Serradell, M., Molinuevo, J. L., Valldeoriola, F., Gelpi, E., Vilaseca, I., Sánchez-Valle, R., Lladó, A., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089741 · Cited by 548
Parkinson risk in idiopathic REM sleep behavior disorder: Preparing for neuroprotective trials
Postuma, R. B., Gagnon, J.-F., Bertrand, J.-A., Génier Marchand, D., & Montplaisir, J. Y. (2015) · Neurology · doi:10.1212/wnl.0000000000001364 · Cited by 436
Self-citation
Cited by
MDS research criteria for prodromal Parkinson's disease
Berg, D., Postuma, R. B., Adler, C. H., Bloem, B. R., Chan, P., Dubois, B., Gasser, T., Goetz, C. G., Halliday, G., Joseph, L., et al. (2015) · Movement Disorders · doi:10.1002/mds.26431 · Cited by 1,309
Self-citationPostuma, R. B., Iranzo, A., Hu, M., Högl, B., Boeve, B. F., Manni, R., Oertel, W. H., Arnulf, I., Ferini-Strambi, L., Puligheddu, M., et al. (2019) · Brain · doi:10.1093/brain/awz030 · Cited by 1,106
Self-citationObeso, J. A., Stamelou, M., Goetz, C. G., Poewe, W., Lang, A. E., Weintraub, D., Burn, D., Halliday, G. M., Bezard, E., Przedborski, S., et al. (2017) · Movement Disorders · doi:10.1002/mds.27115 · Cited by 859
Self-citationThe Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy
Wenning, G. K., Stankovic, I., Vignatelli, L., Fanciulli, A., Calandra‐Buonaura, G., Seppi, K., Palma, J., Meissner, W. G., Krismer, F., Berg, D., et al. (2022) · Movement Disorders · doi:10.1002/mds.29005 · Cited by 833
Siderowf, A., Concha-Marambio, L., Lafontant, D.-E., Farris, C. M., Ma, Y., Urenia, P. A., Nguyen, H., Alcalay, R. N., Chahine, L. M., Foroud, T., et al. (2023) · The Lancet Neurology · doi:10.1016/s1474-4422(23)00109-6 · Cited by 719
Dauvilliers, Y., Schenck, C. H., Postuma, R. B., Iranzo, A., Luppi, P.-H., Plazzi, G., Montplaisir, J., & Boeve, B. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0016-5 · Cited by 492
Self-citationAdvances in markers of prodromal Parkinson disease
Postuma, R. B., & Berg, D. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.152 · Cited by 405
Self-citationThe microbiome–gut–brain axis in Parkinson disease — from basic research to the clinic
Tan, A. H., Lim, S. Y., & Lang, A. E. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-022-00681-2 · Cited by 392
Galbiati, A., Verga, L., Giora, E., Zucconi, M., & Ferini-Strambi, L. (2019) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2018.09.008 · Cited by 367
Self-citationNatural history of pure autonomic failure: A United States prospective cohort
Kaufmann, H., Norcliffe‐Kaufmann, L., Palma, J., Biaggioni, I., Low, P. A., Singer, W., Goldstein, D. S., Peltier, A. C., Shibao, C. A., Gibbons, C. H., et al. (2017) · Annals of Neurology · doi:10.1002/ana.24877 · Cited by 298
The Concept of Prodromal Parkinson’s Disease
Mahlknecht, P., Seppi, K., & Poewe, W. (2015) · Journal of Parkinson's Disease · doi:10.3233/jpd-150685 · Cited by 288
Poewe, W., Stankovic, I., Halliday, G., Meissner, W. G., Wenning, G. K., Pellecchia, M. T., Seppi, K., Palma, J.-A., & Kaufmann, H. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00382-6 · Cited by 279
Iranzo, A., Santamaria, J., & Tolosa, E. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)00057-0 · Cited by 271
Self-citationMultimodal assessment of Parkinson’s disease: a deep learning approach
Vasquez-Correa, J. C., Arias-Vergara, T., Orozco-Arroyave, J. R., Eskofier, B., Klucken, J., & Noth, E. (2019) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2018.2866873 · Cited by 262
Canadian guideline for Parkinson disease
Grimes, D., Fitzpatrick, M., Gordon, J., Miyasaki, J., Fon, E. A., Schlossmacher, M., Suchowersky, O., Rajput, A., Lafontaine, A. L., Mestre, T., et al. (2019) · Canadian Medical Association Journal · doi:10.1503/cmaj.181504 · Cited by 173
Self-citationNon‐Motor Symptoms in Parkinson's Disease are Reduced by Nabilone
Peball, M., Krismer, F., Knaus, H., Djamshidian, A., Werkmann, M., Carbone, F., Ellmerer, P., Heim, B., Marini, K., Valent, D., et al. (2020) · Annals of Neurology · doi:10.1002/ana.25864 · Cited by 123
Bedard, M.-A., Aghourian, M., Legault-Denis, C., Postuma, R. B., Soucy, J.-P., Gagnon, J.-F., Pelletier, A., & Montplaisir, J. (2019) · Sleep Medicine · doi:10.1016/j.sleep.2018.12.020 · Cited by 123
Self-citationMetagenomics of the Gut Microbiome in Parkinson's Disease: Prodromal Changes
Palacios, N., Wilkinson, J., Bjornevik, K., Schwarzschild, M. A., McIver, L., Ascherio, A., & Huttenhower, C. (2023) · Annals of Neurology · doi:10.1002/ana.26719 · Cited by 59
Feinsilver, S. H., & Hernandez, A. B. (2017) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2017.06.009 · Cited by 44
Heart Matters: Cardiac Dysfunction and Other Autonomic Changes in Parkinson’s Disease
Gonçalves, V. C., Cuenca-Bermejo, L., Fernandez-Villalba, E., Martin-Balbuena, S., da Silva Fernandes, M. J., Scorza, C. A., & Herrero, M.-T. (2022) · The Neuroscientist · doi:10.1177/1073858421990000 · Cited by 37
Rapid Eye Movement Sleep Behavior Disorder and Other Rapid Eye Movement Sleep Parasomnias
Ho¨gl, B., & Iranzo, A. (2017) · Continuum · doi:10.1212/con.0000000000000489 · Cited by 30
Self-citationSleep and Circadian Rhythm Disorders in Parkinson’s Disease
Gros, P., & Videnovic, A. (2017) · Current Sleep Medicine Reports · doi:10.1007/s40675-017-0079-y · Cited by 29
Clinical neurophysiology of REM parasomnias
(2019) · Handbook of Clinical Neurology · doi:10.1016/b978-0-444-64142-7.00062-x · Cited by 22
Self-citationCutaneous alpha‐synuclein deposition in postural tachycardia patients
Levine, T. D., Bellaire, B., Gibbons, C., & Freeman, R. (2021) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51347 · Cited by 11
Metadata
- Authors
- Postuma, R. B., Iranzo, A., Hogl, B., Arnulf, I., Ferini‐Strambi, L., Manni, R., Miyamoto, T., Oertel, W., Dauvilliers, Y., Ju, Y., Puligheddu, M., Sonka, K., Pelletier, A., Santamaria, J., Frauscher, B., Leu‐Semenescu, S., Zucconi, M., Terzaghi, M., Miyamoto, M., Unger, M. M., Carlander, B., Fantini, M., & Montplaisir, J. Y.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2015-03-13
- Volume
- 77
- Issue
- 5
- Pages
- 830-839
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2162234212
- Cited by
- 291
- References
- 27
- FWCI
- 25.71
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.